Literature DB >> 16008526

Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.

Pierre-Olivier Hétu1, Denis Riendeau.   

Abstract

Cyclo-oxygenases (COXs) catalyse the synthesis of PGH2 (prostaglandin H2), which serves as the common substrate for the production of PGE2, PGD2, PGF(2alpha), prostacyclin (or PGI2) and TXs (thromboxanes). While COX-1 is the major isoform responsible for prostanoid synthesis in healthy tissues, little information is available on the contribution of constitutive COX-2 to the various prostanoid synthetic pathways under non-inflammatory conditions. To evaluate further the role of COX-2 in prostanoid biosynthesis, rats were acutely treated with the selective COX-1 inhibitor SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole] or the selective COX-2 inhibitors MF tricyclic [3-(3,4-difluorophenyl)-4-(4-(methylsulphonyl)phenyl)-2-(5H)-furanone] and DFU [5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2-(5H)-furanone]. Selected tissues were then processed for a complete analysis of their prostanoid content by liquid chromatography MS. Whereas the treatment with SC-560 caused a 60-70% inhibition in the total prostanoid content of most tissues examined, a significant decrease (35-50%) in total prostanoid content following selective COX-2 inhibition was solely detected for kidney and brain tissues. Analysis of the individual prostanoids reveals significant inhibition of 6-oxo-PGF(1alpha), PGE2, PGD2, PGF(2alpha) and TXB2 in the kidney and inhibition of all these prostanoids with the exception of PGD2 in the forebrain. These results demonstrate that constitutively expressed COX-2 contributes to the production of prostanoids in kidney and brain for each of the PGE2, PGI2 and TXB2 pathways under non-inflammatory conditions. Approaches to modulate inflammation through specific inhibition of terminal synthases, such as mPGES-1 (microsomal PGE2 synthase-1), thus have the potential to differ from COX-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs with regard to effects on constitutive prostanoid synthesis and on renal function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008526      PMCID: PMC1276956          DOI: 10.1042/BJ20050451

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid.

Authors:  D C Swinney; A Y Mak; J Barnett; C S Ramesha
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  Histopathologic changes in laboratory animals resulting from various methods of euthanasia.

Authors:  D B Feldman; B N Gupta
Journal:  Lab Anim Sci       Date:  1976-04

Review 3.  Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.

Authors:  W L Smith; R M Garavito; D L DeWitt
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

4.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

5.  Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.

Authors:  D Riendeau; M D Percival; S Boyce; C Brideau; S Charleson; W Cromlish; D Ethier; J Evans; J P Falgueyret; A W Ford-Hutchinson; R Gordon; G Greig; M Gresser; J Guay; S Kargman; S Léger; J A Mancini; G O'Neill; M Ouellet; I W Rodger; M Thérien; Z Wang; J K Webb; E Wong; C C Chan
Journal:  Br J Pharmacol       Date:  1997-05       Impact factor: 8.739

6.  Characterization of inducible cyclooxygenase in rat brain.

Authors:  C D Breder; D Dewitt; R P Kraig
Journal:  J Comp Neurol       Date:  1995-05-01       Impact factor: 3.215

7.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

Authors:  R C Harris; J A McKanna; Y Akai; H R Jacobson; R N Dubois; M D Breyer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation.

Authors:  F Beiche; S Scheuerer; K Brune; G Geisslinger; M Goppelt-Struebe
Journal:  FEBS Lett       Date:  1996-07-22       Impact factor: 4.124

9.  Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

Authors:  M Oshima; J E Dinchuk; S L Kargman; H Oshima; B Hancock; E Kwong; J M Trzaskos; J F Evans; M M Taketo
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

10.  Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells.

Authors:  S Kargman; E Wong; G M Greig; J P Falgueyret; W Cromlish; D Ethier; J A Yergey; D Riendeau; J F Evans; B Kennedy; P Tagari; D A Francis; G P O'Neill
Journal:  Biochem Pharmacol       Date:  1996-10-11       Impact factor: 5.858

View more
  9 in total

1.  Cyclooxygenase products and atherosclerosis.

Authors:  Macrae F Linton; Sergio Fazio
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 2.  Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs.

Authors:  Noritaka Kawada; Toshiki Moriyama; Harumi Kitamura; Ryohei Yamamoto; Yoshiyuki Furumatsu; Isao Matsui; Yoshitsugu Takabatake; Yasuyuki Nagasawa; Enyu Imai; Christopher S Wilcox; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

3.  Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue.

Authors:  Rikke Nørregaard; Boye L Jensen; Sukru Oguzkan Topcu; Guixian Wang; Horst Schweer; Søren Nielsen; Jørgen Frøkiaer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

4.  Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population.

Authors:  Luis Vila; Angel Martinez-Perez; Mercedes Camacho; Alfonso Buil; Sonia Alcolea; Nuria Pujol-Moix; Marta Soler; Rosa Antón; Juan-Carlos Souto; Jordi Fontcuberta; José-Manuel Soria
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-22       Impact factor: 8.311

5.  Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

Authors:  Marganit Benish; Inbal Bartal; Yael Goldfarb; Ben Levi; Roi Avraham; Amiram Raz; Shamgar Ben-Eliyahu
Journal:  Ann Surg Oncol       Date:  2008-04-09       Impact factor: 5.344

Review 6.  Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.

Authors:  Kerstin Hiesinger; Karen M Wagner; Bruce D Hammock; Ewgenij Proschak; Sung Hee Hwang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-12-26       Impact factor: 3.072

7.  Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.

Authors:  S Saleem; Z A Shah; Y Urade; S Doré
Journal:  Neuroscience       Date:  2009-02-28       Impact factor: 3.590

Review 8.  Effects of nitric oxide on magnocellular neurons of the supraoptic nucleus involve multiple mechanisms.

Authors:  M P da Silva; P L Cedraz-Mercez; W A Varanda
Journal:  Braz J Med Biol Res       Date:  2014-01-17       Impact factor: 2.590

9.  Pre- and Neonatal Exposure to Lead (Pb) Induces Neuroinflammation in the Forebrain Cortex, Hippocampus and Cerebellum of Rat Pups.

Authors:  Karina Chibowska; Jan Korbecki; Izabela Gutowska; Emilia Metryka; Maciej Tarnowski; Marta Goschorska; Katarzyna Barczak; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.